
Pegasta Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Pegfilgrastim (6mg)
Overview Pegasta Injection
Filgrastim injection helps prevent infections following chemotherapy. This medication, a growth factor, stimulates bone marrow to produce infection-fighting white blood cells. Administration is by injection from a qualified healthcare provider, and treatment duration depends on your doctor's assessment and your individual response. Regular blood tests, including white blood cell counts and bone density checks, may be required. Common side effects include bone, joint, and muscle pain, headache, and nausea; injection site pain, redness, or swelling may also occur. Report persistent lumps, swelling, or bruising. While it doesn't guarantee complete infection protection, contact your doctor immediately if you experience fever, chills, respiratory distress, sore throat, or facial/neck swelling. Inform your healthcare team of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment. Avoid driving or activities requiring alertness if dizziness occurs.
Primary Ingredients of Pegasta Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Pegasta Injection
Protecting against infection following chemotherapy
Major Benefits of Pegasta Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pegasta Injection:
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Pegasta Injection:
The medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Pegasta Injection works:
Pegasta Injection is a bone marrow stimulant, promoting the production of infection-fighting white blood cells. This growth factor enhances the body's immune defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pegasta Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pegasta Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Employing Pegasta Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Pegasta Injection.
KidneySAFE IF PRESCRIBED
Pegasta Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCONSULT YOUR DOCTOR
Data regarding Pegasta Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Pegasta Injection :
Omit a Pegasta Injection dose? Seek your physician's advice.
Facts to Know About Pegasta Injection
| Label | Value |
|---|---|
| Chemical Category | Granulocyte colony-stimulating factor |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | G-CSF (granulocyte colony-stimulating factor) |
